Please login to the form below
Fluad
This page shows the latest Fluad news and features for those working in and with pharma, biotech and healthcare.
Novavax announces positive phase 2 results for COVID-19/influenza vaccine candidates
For the stand-alone influenza vaccine candidate, haemagglutination inhibition (HAI) antibody responses were 31% to 56% higher for all four strains compared to Fluad, and 44% to 89% higher for A
Latest news
-
Incisive Health and 90TEN take home Integrated Communications awards
The partners built advocacy throughout the UK influenza network, and helped bring about major changes in UK influenza guidance from the JCVI and NHS England on the use of Fluad as
-
Italy investigates Novartis vaccine after death toll reaches 13
Firms insist on the Fluad's safety, with 65 million doses given in the last 17 years. ... Fluad has been on the market since 1997 and Novartis insisted that it has a "robust safety history" with some 65 million doses delivered over the last 17 years.
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
Influenza – the risk to vulnerable populations
and Fluzone High-Dose Quadrivalent (Influenza Vaccine) by Sanofi Pasteur and Fluad Quadrivalent(Influenza Vaccine, Adjuvanted) by CSL Seqirus UK. ... Fluad Quadrivalent contains an adjuvant called MF59 that is added to the vaccine to help boost the
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- AbbVie’s Rinvoq receives FDA approval for Crohn’s disease
- Bayer’s Nubeqa combination recommended by NICE to treat metastatic prostate cancer
- AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer
- Novo Nordisk announces positive phase 3 results for oral weight-loss drug
- COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP
- FDA approves Blueprint Medicines’ Ayvakit for indolent systemic mastocytosis
- Medscape Medical Affairs Selected as Finalist for 2023 Communiqué Awards
- COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Gene therapy, gene editing and perspectives on future use in Parkinson’s disease
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- Shining a Spotlight on Women’s Health Education Outcomes at ACOG 2023
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- ...
- Working together to achieve better patient pathways
- Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
- Design-thinking. Iterating for continuous improvement.
- How design can lead improvement within Pharma...
